Subscribe To
89bio: great prospects after excellent phase 2 data
ETNB posted excellent phase 2 data in March. They plan to start a ...
May 28, 2023, 4:18 am
Usdcad weekly analysis – may 27, 2023
The USDCAD currency pair has displayed a resilient uptrend, remaining within a rising price channel on the weekly chart. This upward movement has been...
May 27, 2023, 4:58 am
Gbpusd weekly analysis – may 27, 2023
The GBPUSD currency pair has recently broken below a rising trend line on the weekly chart, indicating that a period of consolidation for the uptrend ...
May 27, 2023, 4:35 am
Eurusd weekly analysis – may 27, 2023
The EURUSD currency pair has entered a consolidation phase within the context of its overall uptrend fr...
May 27, 2023, 4:27 am
Pds biotechnology: promising interim hnscc data reaffirms investment prospects
PDS Biotech's phase 2 study shows potential breakthrough in treating HPV16-positive head and neck cance...
May 27, 2023, 3:40 am
Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...
May 26, 2023, 9:10 pm
Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...
May 26, 2023, 5:10 pm
Apellis' (apls) study on pegcetacoplan to treat als fails
Apellis' (APLS) phase II MERIDIAN study on pegcetacoplan for the treatment of amyotrophic lateral scler...
May 26, 2023, 12:05 pm
Enphase (enph) launches iq battery 5p in the us and puerto rico
Enphase (ENPH) introduces IQ Battery 5P for customers in the United States and Puerto Rico....
May 26, 2023, 9:05 am
Why is effector therapeutics (eftr) stock up 75% today?
EFFECTOR Therapeutics (NASDAQ: EFTR ) stock is taking off on Friday after the company reported positive data from a ...
May 26, 2023, 8:28 am
Genprex says positive data from acclaim-1 clinical trial to be published at 2023 asco meeting
Genprex Inc. (NASDAQ:GNPX) said positive data from the phase 1 portion of its Acclaim-1 clinical trial ...
May 26, 2023, 8:06 am
Astrazeneca hails the findings from cancer combination trial
AstraZeneca PLC (LSE:AZN) has hailed the potential of a highly targeted combination of its own drugs with chemotherapy in the battle against endometr...
May 26, 2023, 2:41 am
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a
– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...
May 25, 2023, 9:15 pm
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 asco annual meeting
– Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools – –...
May 25, 2023, 9:05 pm
Fcm concerned mindmed’s mismanagement threatens mental health for millions
MindMed has Slashed Allocation of Spending on Core Drugs While Executive Compensation has Soared to $51M MindMed ...
May 25, 2023, 8:57 pm
Effector therapeutics reports positive data updates from phase 2 expansion cohorts evaluating zotatifin in patients with er+ metastatic breast cancer at the asco 2023 annual meeting
Partial responses observed in 5 of 19 (26%) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib (ZFA triple...
May 25, 2023, 8:50 pm
Structure therapeutics initiates phase 2a study of oral glp-1 agonist gsbr-1290 for the treatment of type 2 diabetes and obesity
12-week phase 2a and phase 1b multiple ascending dose (M...
May 25, 2023, 8:30 pm
Roche, with ocrevus and fenebrutinib advancement, should be top ms contender
It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS cou...
May 25, 2023, 7:36 pm
Tesla will bring its supercharger network to ford, a competitor in the ev market, to hep bring the car company to 'equal footing,' elon musk says
During a live audio-only interview on Twitter, Elon Musk and Jim Farley spoke about how to usher in the next p...
May 25, 2023, 6:00 pm